Genfit Sa Share Price

NASDAQ: GNFT

Small Cap

$4.25

+0.06

(+1.38%)

as on September 13, 2025 at 1:25 am IST

$₹

Genfit Sa Stock Performance

as on September 13, 2025 at 1:25 am IST

Day's High
$4.25
Day's Price Range
$4.3
$4.25
1.18%
Upside
52 Week's Low
52 Week's High
$2.55
52-Week Price Range
$6.42
$4.25
40.00%
Downside
51.13%
Upside

Genfit Sa share price movements today

Previous Close: $4.19
Open: $4.26
Volume: 95.0K
Day's Low - High: $4.25 - $4.3
52 Week Low - High: $2.55 - $6.42

Genfit Sa Historical Returns

1 Month Return: + 4.17 %
3 Month Return: + 3.61 %
1 Year Return: + 3.61 %
3 Year Return: -3.89 %
5 Year Return: -8.65 %

Genfit Sa Stock Fundamentals & Key Indicators

Check Genfit Sa market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$212.4M

EPS (TTM)

0.01

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

106.2

Industry PE ratio

P/B Ratio

106.1975

PEG Ratio

EBITDA

4.7M

Revenue (TTM)

70.7M

Profit Margin

2.13%

Return On Equity TTM

2.20%

Genfit Sa Stock Valuation

Track how Genfit Sa P/E has moved over time to understand its valuation trends.

Genfit Sa in the last 5 years

Overview
Trends

Lowest (11.32x)

June 30, 2024

Industry (0.00x)

September 13, 2025

Today (106.20x)

September 13, 2025

Highest (41.74x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 106.20x

Genfit Sa vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Genfit Sa with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Genfit Sa	BUY	$212.4M	-8.65%	106.2	2.13%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Genfit Sa Stock including INR - Dollar returns

The Genfit Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Genfit Sa investment value today

Current value as on today

₹1,08,798

Returns

₹8,798

(+8.8%)

Returns from Genfit Sa Stock

₹3,659 (+3.66%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Genfit Sa Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Genfit Sa. Average target price of $9.05

Genfit Sa Share Price Target

Get share price movements and forecasts by analysts on Genfit Sa.

What analysts predicted

53.04%UPSIDE

Target Price

$9.05

Current Price

$4.25

Analyzed by

13 Analysts

Target

$9.05

Genfit Sa target price $9.05, a slight upside of 53.04% compared to current price of $4.25. According to 13 analysts rating.

Genfit Sa Stock's Interest Amongst Investors

Search interest for Genfit Sa Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 15, 2025 to September 14, 2025

Change:67% versus previous 30 day period

Genfit Sa Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Dec 2024
Total Revenue	9	5	6	8	12	3	15	33	65	8
Gross Profit	12	5	6	8	16	3	21	33	64	-
Operating Income	-17	5	6	-9	-23	2	5	15	31	-31
EBITDA	-13	5	-13	-9	-19	2	-7	16	32	-24
Interest Expense	2	-	2	2	2	-	3	3	2	2
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-13	-6	-16	-10	-23	-4	-8	15	30	-28
Income Tax Expense	-3	0	-2	0	-3	0	0	0	0	0
Net Income	-10	-6	-14	-11	-22	-4	-8	16	32	-28
Net Profit Margin	-118.30%	-125.42%	-218.54%	-138.01%	-181.62%	-142.65%	-56.36%	49.61%	49.61%	-358.75%

Genfit Sa Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	34	0	90	21	31	70
Gross Profit	-1	-1	-2	-2	34	0	90	21	30	69
Operating Income	-17	-34	-56	-69	-57	-77	76	-27	-26	3
EBITDA	-17	-33	-55	-68	-51	-91	34	-23	-22	8
Interest Expense	-	0	2	10	11	11	7	4	4	4
Depreciation	-	-	1	1	3	3	2	1	1	1
Income Before Tax	-17	-33	-58	-79	-65	-101	69	-23	-28	1
Income Tax Expense	0	0	0	0	0	0	2	0	0	0
Net Income	-18	-35	-69	-90	-72	-123	76	-25	-31	1
Net Profit Margin	-3251.42%	-11854.58%	-49664.41%	-115247.83%	-211.24%	-13231.50%	84.00%	-117.45%	-101.15%	2.25%

Genfit Sa Quarterly Cash Flow

All numbers in Millions USD

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Dec 2024
Net Income	-6	-13	-10	-20	-4	-8	15	30	-28
Operating Cash Flow	-12	-26	-12	-25	-15	-30	-5	-11	26
Investing Cash Flow	1	-46	1	2	0	0	0	0	0
Financing Cash Flow	0	0	0	0	-1	-3	-2	-4	-6
Change in Cash	-36	-73	-12	-24	-111	-34	-8	61	-

Genfit Sa Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-33	-58	-79	-65	-101	67	-23	-28	1
Operating Cash Flow	-27	-49	-56	-47	-96	99	-72	-55	15
Investing Cash Flow	-2	-2	-3	0	0	-3	-46	2	-1
Financing Cash Flow	121	174	-6	116	-8	-8	-3	-5	-10
Change in Cash	92	121	-66	69	-105	87	-122	-58	3

Global Institutional Holdings in Genfit Sa

Funds	Holdings
Millennium Management LLC	0.26%
Morgan Stanley - Brokerage Accounts	0.05%
OLD MISSION CAPITAL LLC.	0.04%
Optiver Holding B.V.	0.03%
Citadel Advisors Llc	0.02%

See all

Insights on Genfit Sa

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, GNFT stock has moved up by 9.1%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 70.8%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 123.0%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 61.10M → 8.02M (in $), with an average decrease of 86.9% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 30.31M → -28.80M (in $), with an average decrease of 195.0% per quarter

About Genfit Sa

genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver (such as nash - nonalcoholic steatohepatitis) or the bowel (such as the inflammatory bowel disease). genfit is committed to contribute to bringing new medicines to market for patients who lack suitable solutions, and strives to implement mutually beneficial approaches that combine novel drugs and biomarkers. its research programs have resulted in the creation of a rich and diversified pipeline of drug candidates, including genfit’s lead proprietary compound, gft505, that is completing a phase 2b study in nash.

Organisation	Genfit Sa
Headquarters	Parc EurasantE, Loos, France, 59120
Industry	Biotechnology
CEO	Mr. M. Pascal Prigent
E-voting on shares	Click here to vote

Key Management of Genfit Sa

Name	Title
Mr. M. Pascal Prigent	Chief Executive Officer
Prof. Bart Staels	Co-Founder & Chairman of the Scientific Advisory Board
Mr. Thomas Baetz	Chief Financial Officer
Mr. Pascal Caisey	Chief Operating Officer
Ms. Emilie Desodt	Executive Vice President of Human Resources
Mr. Jean-Francois Mouney	Co-Founder & Chairman of the Board
Dr. Dean W. Hum Ph.D.	Chief Scientific Officer
Mr. Jean-Christophe Marcoux	Chief Corporate Affairs Officer, Head of Investor Relations & Head of ESG
Mr. Laurent Lannoo	Corporate Secretary & Director of Legal Affairs
Ms. Stefanie Magner J.D.	Chief Compliance Officer & Executive VP of International Legal Affairs

FAQs

What is Genfit Sa share price today?

Genfit Sa share price today is $4.25 as on September 13, 2025 at 1:25 am IST at the close of the market. Genfit Sa share today touched a day high of $4.3 and a low of $4.25.

What is the 52 week high and 52 week low for Genfit Sa share?

Genfit Sa share touched a 52 week high of $6.42 on October 17, 2024 and a 52 week low of $2.55 on April 9, 2025. Genfit Sa stock price today i.e. September 13, 2025 at 1:25 am IST is closed at $4.25,which is 33.83% down from its 52 week high and 66.67% up from its 52 week low.

What is Genfit Sa's market capitalisation today?

Genfit Sa market capitalisation is $0.00T as on September 13, 2025 at 1:25 am IST.

How to invest in Genfit Sa Stock (GNFT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Genfit Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genfit Sa Shares that will get you 0.3529 shares as per Genfit Sa share price of $4.25 per share as on September 13, 2025 at 1:25 am IST.

What is the minimum amount required to buy Genfit Sa Stock (GNFT) from India?

Indian investors can start investing in Genfit Sa (GNFT) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 10:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Genfit Sa stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 10:38 am IST). Based on Genfit Sa share’s latest price of $4.25 as on September 13, 2025 at 1:25 am IST, you will get 2.3529 shares of Genfit Sa. Learn more about fractional shares .

What are the returns that Genfit Sa has given to Indian investors in the last 5 years?

Genfit Sa stock has given -8.65% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?